Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SINT
SINT logo

SINT Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy SINTX Technologies Inc (SINT) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.350
1 Day change
-1.67%
52 Week Range
6.780
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

SINTX Technologies Inc (SINT) is not a strong buy at this time for a beginner investor with a long-term investment strategy. The lack of positive financial performance, weak technical indicators, and absence of significant positive catalysts make it prudent to hold off on investing in this stock for now.

Technical Analysis

The MACD is slightly positive but contracting, indicating weak momentum. The RSI is neutral at 33.905, and moving averages are converging, suggesting no clear trend. The stock is trading near its pivot level of 2.737, with resistance at 2.924 and support at 2.55. Overall, the technical indicators do not signal a strong buy opportunity.

Positive Catalysts

  • Analyst coverage from H.C. Wainwright initiated with a Buy rating and a $10 price target, citing the company's innovative silicon nitride-based biomaterials and potential for commercial growth.

Neutral/Negative Catalysts

  • No recent news or significant trading trends from insiders or hedge funds. Financial performance in Q4 2025 shows a sharp revenue decline (-46.49% YoY) and a drop in EPS (-54.76% YoY). Stock trend analysis predicts a negative performance in the short to medium term (-0.05% next day, -0.36% next week, -6.13% next month).

Financial Performance

In Q4 2025, revenue dropped significantly by 46.49% YoY to $290,000. Net income improved but remains negative at -$2,215,000 (up 30.68% YoY). EPS declined sharply to -0.57 (-54.76% YoY), and gross margin fell to 64.83% (-9.44% YoY). Overall, the financials indicate weak growth trends.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

H.C. Wainwright initiated coverage with a Buy rating and a $10 price target, citing the company's innovative product offerings and potential for commercial growth. However, no other recent analyst updates or changes in price targets are available.

Wall Street analysts forecast SINT stock price to rise
1 Analyst Rating
Wall Street analysts forecast SINT stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 2.350
sliders
Low
16
Averages
16
High
16
Current: 2.350
sliders
Low
16
Averages
16
High
16
H.C. Wainwright
H.C. Wainwright
initiated
$10
AI Analysis
2026-04-13
Reason
H.C. Wainwright
H.C. Wainwright
Price Target
$10
AI Analysis
2026-04-13
initiated
Reason
H.C. Wainwright initiated coverage of Sintx Technologies with a Buy rating and $10 price target. Sintx is developing silicon nitride-based biomaterials, which offer a \"differentiated combination\" of antimicrobial properties and bone integration that can disrupt traditional orthopedic implant materials, the analyst tells investors in a research note. The firm sees the company entering a \"more relevant\" commercial phase, supported by expanding applications and growing external validation.

People Also Watch